Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Paul Reed
  • November 23, 2020
  • Articles

Facial analysis in emerging markets

Facial analysis in emerging markets

One of the latest innovations in market research is facial and emotional analysis using artificial intelligence. This technology employs recognition software to detect emotional insights from facial expressions, which can enhance research by delving further into respondents’ reactions to healthcare communications or other stimuli. Complementary tools can be used to elicit additional meaning from tone of voice, through to laughter and anger.

read more »

  • Posted by Pei Li Teh & Callum McCulloch
  • December 3, 2019
  • Webinars

Webcast: Portfolio analysis - Go/No-go decisions

Webcast: Portfolio analysis - Go/No-go decisions

When a pharma company is either considering acquiring a new agent, or developing one in-house, marketers need to understand the impact on the overall portfolio and decide whether to make a go or no-go decision on that asset. Watch this webcast in which Research Partnership's Pei Li Teh and Callum McCulloch (who are both from our Singapore office) discuss how market research insights allow you to make confident go/no-go decisions in portfolio planning.

read more »

  • Posted by Wan Ling Neo & Ethel Gay
  • November 7, 2019
  • Webinars

Webcast: Portfolio analysis - Tracking for success

Webcast: Portfolio analysis - Tracking for success

Portfolio Analysis and Optimization looks at how honing strategy across multiple agents in the same therapeutic category leads to marketing success. As pharmaceutical companies simultaneously develop and in-license multiple products that can cost millions of dollars, portfolio management is about selecting how to allocate resources and marketing efforts across multiple assets. This has significant impact on the bottom line. 

read more »

  • Posted by Pei Li Teh & Colin Tan
  • October 1, 2019
  • Webinars

Webcast: Portfolio analysis - Choosing your communication strategy

Webcast: Portfolio analysis - Choosing your communication strategy

Portfolio Analysis and Optimization concentrates on determining the impact that multiple assets have within therapeutic categories, and how the marketing of these assets impacts on overall strategy. This is an important tool for pharmaceutical companies in today’s market. As they simultaneously develop multiple products that can become extremely costly, portfolio management to improve decision-making can have a significant impact on the bottom line. At its very core, it is about selecting how to allocate resources and marketing efforts across multiple assets. 

read more »

  • Posted by Julie Denny
  • August 1, 2019
  • Articles

Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma

Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma

Marketing Director Julie Denny was recently interviewed by PME Magazine about the use of artificial intelligence in pharma marketing and market research.

Rumours that robots will eventually wipe out humans are the futuristic stuff of Hollywood blockbusters. The real-world story arc is much more uplifting but no less dramatic. When a homeless man in central England was crushed to death by a compaction unit as he slept in the dustbin in 2013, it triggered a response from the UK waste management industry that now sees many refuse trucks fitted with senor technology to detect people in bins. It's an early example of how AI can literally save lives. Fast forward six years and we've now got 'robot doctors' detecting cancers, smart remote monitoring systems managing patients miles from their homes and algorithm-led technologies predicting long-term health based on individuals' DNA. The application of AI in health isn't science fiction, it's happening fast - and it’s positively disrupting patient care. 

read more »